Control metabólico y satisfacción de un programa de educación diabetológica en monitorización flash de glucosa mediante telemedicina en diabetes tipo 1

Endocrinologia, Diabetes y Nutricion - Tập 70 - Trang 408-414 - 2023
María de la O Nieto de la Marca1,2, Gonzalo Díaz-Soto1,2, Marta Sánchez Ibáñez1,2, Sofía del Amo Simón1, Pablo Fernández Velasco1,2, Beatriz Torres Torres1,2, Juan José López Gómez1,2, Emilia Gómez Hoyos1,2, Ana Ortolá Buigues1,2, Esther Delgado García1,2, Daniel de Luis Román1,2
1Servicio de Endocrinología y Nutrición, Hospital Clínico Universitario Valladolid, Valladolid, España
2Centro de Investigación de Endocrinología y Nutrición. Facultad de Medicina Valladolid, Valladolid, España

Tài liệu tham khảo

Alva, 2020, Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes, J Diabetes Sci Technol., 16, 70, 10.1177/1932296820958754 Ang, 2020, Flash glucose monitoring (FGM): A clinical review on glycaemic outcomes and impact on quality of life, J Diabetes Complications., 34, 107559, 10.1016/j.jdiacomp.2020.107559 El Malahi, 2022, Relationship between time in range, glycemic variability HbA1c and complications in adults with type 1 diabetes mellitus, J Clin Endocrinol Metab., 107, e570, 10.1210/clinem/dgab688 Gomez-Peralta, 2020, Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain, BMJ Open Diabetes Res Care., 8, e001052, 10.1136/bmjdrc-2019-001052 Hermanns, 2019, The impact of a structured education and treatment programme (FLASH) for people with diabetes using a flash sensor-based glucose monitoring system: Results of a randomized controlled trial, Diabetes Res Clin Pract., 150, 111, 10.1016/j.diabres.2019.03.003 Bolinder, 2016, Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial, Lancet., 388, 2254, 10.1016/S0140-6736(16)31535-5 Secretaría de Estado de Sanidad. Resol_Flash_2020.pdf. [En línea] [consultado 01 Sep 2021]. Disponible en: https://www.mscbs.gob.es/profesionales/prestacionesSanitarias/CarteraDeServicios/ContenidoCS/docs/Resol_Flash_2020.pdf. Haak, 2017, Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial, Diabetes Ther., 8, 55, 10.1007/s13300-016-0223-6 Verhoeven, 2007, The contribution of teleconsultation and videoconferencing to diabetes care: a systematic literature review, J Med Internet Res., 9, e37, 10.2196/jmir.9.5.e37 McDonnell, 2018, Telemedicine in Complex Diabetes Management, Curr Diab Rep., 18, 42, 10.1007/s11892-018-1015-3 Battelino, 2019, Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range, Diabetes Care., 42, 1593, 10.2337/dci19-0028 Danne, 2021, Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future, Diabetes Ther., 12, 2289, 10.1007/s13300-021-01114-x Giustina, 2021, One year of the pandemic - how European endocrinologists responded to the crisis: a statement from the European Society of Endocrinology, Eur J Endocrinol., 185, C1, 10.1530/EJE-21-0397 Zugasti-Murillo, 2021, How the COVID-19 pandemic has affected the training of endocrinology and nutrition residents. Results of a survey by the Spanish Society of Endocrinology and Nutrition, Endocrinol Diabetes Nutr., 69, 219, 10.1016/j.endinu.2021.05.005 Gal, 2020, Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose Monitoring, J Endocr Soc., 4, bvaa076, 10.1210/jendso/bvaa076 Scott, 2021, Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic-Results of a global survey, Endocrinol Diabetes Metab., 4, e00180, 10.1002/edm2.180 Oskarsson, 2018, Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial, Diabetologia., 61, 539, 10.1007/s00125-017-4527-5 Díaz-Soto, 2021, The relationship between glycosylated hemoglobin, time-in-range and glycemic variability in type 1 diabetes patients under flash glucose monitoring, Endocrinol Diabetes Nutr., 68, 465, 10.1016/j.endinu.2020.09.008 Wilmot, 2021, Time in range: A best practice guide for UK diabetes healthcare professionals in the context of the COVID-19 global pandemic, Diabet Med., 38, e14433, 10.1111/dme.14433